Speaker illustration

Doctor Takeshi Yamashita

The Cardiovascular Institute, Tokyo (Japan)

Impact of polypharmacy on clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Stroke in Atrial Fibrillation

Session: Atrial fibrillation e-posters

Thumbnail

Real-world effectiveness and the safety of anticoagulant treatment in elderly non-valvular atrial fibrillation in the ANAFIE registry, the largest real-world elderly AF registry

Event: ESC Congress 2020

Topic: Stroke in Atrial Fibrillation

Session: Oral Anticoagulant Therapy in the Elderly with Atrial Fibrillation

Thumbnail

Edoxaban treatment of elderly patients with atrial fibrillation in routine clinical practice: 1-year results of the non-interventional Global ETNA-AF program

Event: ESC Congress 2020

Topic: Oral Anticoagulation

Session: Oral Anticoagulant Therapy in the Elderly with Atrial Fibrillation

Thumbnail

Real-world effectiveness and the safety of anticoagulant treatment in elderly non-valvular atrial fibrillation in the ANAFIE registry, the largest real-world elderly AF registry

Event: ESC Asia with APSC & AFC 2020

Topic: Stroke in Atrial Fibrillation

Session: Abstract Programme

Thumbnail

Edoxaban treatment of elderly patients with atrial fibrillation in routine clinical practice: 1-year results of the non-interventional Global ETNA-AF program

Event: ESC Asia with APSC & AFC 2020

Topic: Oral Anticoagulation

Session: Abstract Programme

Thumbnail